ELV
Elevance Health, Inc. β’ Healthcare (#8 of 11)
$388.50
-2.77 (-0.71%)
View:
Close:$388.50
Vol:EXTREME(100%ile)
Ratio:1.91x
|RSI:47(Neutral)
MACD:β
β₯75%25-75%<25%
Vol.%
Sector Rotation
2026-06-18(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRALβ²1 UpβΌ0 Down8 Hold
Jun 8Mizuho
βOutperform
Jun 8JP Morgan
βOverweight
Jun 4B of A Securities
βBuy
Jun 4Morgan Stanley
βEqual-Weight
Jun 1Truist Securities
βBuy
May 26Barclays
βOverweight
May 22UBS
βBuy
May 20Mizuho
βOutperform
May 20Deutsche Bank
β²Hold β Buy
Price Targets
β²9 RaisesβΌ0 Lowers+16.2% avg
Jun 8Mizuho
$435β$465+6.9%
Jun 8JP Morgan
$411β$476+15.8%
Jun 4B of A Securities
$435β$460+5.7%
Jun 4Morgan Stanley
$352β$404+14.8%
Jun 1Truist Securities
$375β$450+20.0%
May 26Barclays
$408β$480+17.6%
May 22UBS
$400β$460+15.0%
May 20Mizuho
$385β$435+13.0%
May 20Deutsche Bank
$363β$498+37.2%
Trade Setup
ATR-basedEntry$388.50
Target$410.13 (+5.6%)
Stop$372.28
R/R1.33
Risk-4.2%
ATR$10.82
Simple setup: 1.5x ATR stop, 2x ATR target
Risk Metrics
Sharpe (20d)
-0.45Losing
Volatility (20d)
32.2%Normal
Beta (60d)
0.32Defensive
Alpha (20d)
-2.5%Moderate-
News Analysis
EN
δΈ
ν
ζ₯
No analysis record found.